Mirum Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRM and other ETFs, options, and stocks.About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
CEOChristopher Peetz
CEOChristopher Peetz
Employees322
Employees322
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded2018
Founded2018
Employees322
Employees322
MIRM Key Statistics
Market cap4.03B
Market cap4.03B
Price-Earnings ratio-90.59
Price-Earnings ratio-90.59
Dividend yield—
Dividend yield—
Average volume984.13K
Average volume984.13K
High today$80.00
High today$80.00
Low today$75.98
Low today$75.98
Open price$79.24
Open price$79.24
Volume1.30M
Volume1.30M
52 Week high$82.58
52 Week high$82.58
52 Week low$36.88
52 Week low$36.88
Stock Snapshot
As of today, Mirum Pharmaceuticals(MIRM) shares are valued at $77.90. The company's market cap stands at 4.03B, with a P/E ratio of -90.59.
On 2026-01-04, Mirum Pharmaceuticals(MIRM) stock moved within a range of $75.98 to $80.00. With shares now at $77.90, the stock is trading +2.5% above its intraday low and -2.6% below the session's peak.
Trading activity shows a volume of 1.3M, compared to an average daily volume of 984.13K.
The stock's 52-week range extends from a low of $36.88 to a high of $82.58.
The stock's 52-week range extends from a low of $36.88 to a high of $82.58.
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MIRM. This list is generated using Robinhood data, and it’s not a recommendation.